Epperly Melissa B, (CIK 0001807359)

Latest company ownership

Shares held
451,449
Last filed at
Feb 12, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q2 2025Q4
Shares held
56,904
Last filed at
Oct 22, 2025
Confidence Score
58.1
2025Q4
Confidence Score History
2024Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Sep 10, 2025 Sep 12, 2025 Roivant Sciences Ltd. Director Sell 91.3 +12,863 29.92% ✗ $22.9K
Jan 23, 2025 Jan 27, 2025 Roivant Sciences Ltd. Director Sell 82.5 +1,492 3.92% ✗ $2K
Sep 12, 2024 Sep 16, 2024 Roivant Sciences Ltd. Director Sell 42.5 -4,245 -10.44% ✗ $51.4K
Apr 24, 2024 Apr 26, 2024 Roivant Sciences Ltd. Director Sell 82.5 +1,023 4.75% ✗ $1.3K
Feb 12, 2024 Feb 12, 2024 Zentalis Pharmaceuticals, Inc. CFO Sell 51.3 -2,573 -0.57% ✓ $29.4K
Feb 1, 2024 Feb 5, 2024 Zentalis Pharmaceuticals, Inc. CFO Sell 95.0 +66,331 17.11% ✓ $100K
Oct 4, 2023 Oct 6, 2023 Zentalis Pharmaceuticals, Inc. CFO Sell 45.0 -5,482 -1.39% ✓ $106.9K
Feb 13, 2023 Feb 14, 2023 Zentalis Pharmaceuticals, Inc. CFO Sell 45.0 -7,851 -1.96% ✓ $158K
Apr 4, 2022 Apr 5, 2022 Zentalis Pharmaceuticals, Inc. CFO Sell 30.0 -17,080 -6.46% ✓ $855.5K
Feb 23, 2022 Feb 23, 2022 Zentalis Pharmaceuticals, Inc. CFO Sell 47.5 -1,913 -0.72% ✓ $93.9K
Oct 2, 2021 Oct 4, 2021 Zentalis Pharmaceuticals, Inc. CFO Sell 17.5 -17,080 -6.40% ✗ $1.1M
Aug 18, 2021 Aug 20, 2021 Zentalis Pharmaceuticals, Inc. CFO Buy 90.0 +9,611 3.74% ✗ $499.7K
Jul 1, 2021 Jul 6, 2021 Zentalis Pharmaceuticals, Inc. CFO Sell 45.0 -3,083 -1.19% ✓ $158.1K
Jun 1, 2021 Jun 2, 2021 Zentalis Pharmaceuticals, Inc. CFO Sell 45.0 -3,083 -1.17% ✓ $166.6K
May 3, 2021 May 5, 2021 Zentalis Pharmaceuticals, Inc. CFO Sell 45.0 -3,083 -1.16% ✓ $182.6K
Apr 5, 2021 Apr 6, 2021 Zentalis Pharmaceuticals, Inc. CFO Sell 30.0 -17,107 -6.04% ✓ $742.3K
Mar 1, 2021 Mar 3, 2021 Zentalis Pharmaceuticals, Inc. CFO Sell 45.0 -3,083 -1.08% ✓ $128.5K
Feb 1, 2021 Feb 3, 2021 Zentalis Pharmaceuticals, Inc. CFO Sell 45.0 -3,083 -1.12% ✓ $115.8K
Jan 4, 2021 Jan 6, 2021 Zentalis Pharmaceuticals, Inc. CFO Sell 45.0 -3,083 -1.11% ✓ $160K
Dec 4, 2020 Dec 8, 2020 Zentalis Pharmaceuticals, Inc. CFO Sell 35.0 -13,684 -4.70% ✓ $714.1K
Dec 2, 2020 Dec 3, 2020 Zentalis Pharmaceuticals, Inc. CFO Sell 45.0 -3,083 -1.05% ✓ $158.7K
Apr 7, 2020 Nov 25, 2020 Zentalis Pharmaceuticals, Inc. CFO Buy 90.0 +16,917 6.10% ✓ $216.4K